Rajendar Deora
Immunology and Microbiology · The Ohio State University
Publications
70
Citations
2,949
Est. group size
~9
Recurring co-author estimate
Active years
32
Publishing since 1995
- A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice
npj Vaccines · 2026
- Erratum for Carbonetti et al., “Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development”
UNC Libraries · 2025
- The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming
Frontiers in Immunology · 2024
- Opposing effects of acellular and whole cell pertussis vaccines on <i>Bordetella pertussis</i> biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Persistence of Bordetella pertussis as aggregates within nasal tissues of aPV immunized mice prevents recruitment of Siglec-F+ neutrophils and bacterial clearance
The Journal of Immunology · 2024
- Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
Frontiers in Immunology · 2023
- Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epithelium
PLoS Pathogens · 2023
- Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology
The Journal of Immunology · 2023
- Development of a next generation pertussis vaccine: An unbiased biochemical approach to identify novel CD4+ T cell recognized antigens from <i>Bordetella pertussis</i>
The Journal of Immunology · 2023
- Genomic, morphological, and biochemical analyses of a multi-metal resistant but multi-drug susceptible strain of Bordetella petrii from hospital soil
Scientific Reports · 2022
- Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen
PLoS Pathogens · 2022
- Development of carbohydrate based next-generation anti-pertussis vaccines
Bioorganic & Medicinal Chemistry · 2022
- Bps polysaccharide of <i>Bordetella pertussis</i> resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts <i>Escherichia coli</i> into a respiratory pathogen
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathology
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti‐pertussis Vaccine
Angewandte Chemie International Edition · 2020
- PLoS Pathogens×4
- Infection and Immunity×4
- The Journal of Immunology×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Frontiers in Immunology×2
- Steven D. Goodman
Immunology and Microbiology · The Ohio State University
- Evan Billings
Immunology and Microbiology · Purdue University West Lafayette
- Kevin M. Mason
Immunology and Microbiology · The Ohio State University
- Jesse M. Hall
Immunology and Microbiology · The Ohio State University
- Frederick W. Bauer
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile